Managing Anxiety in Pediatric Primary Care (MAPP)
Key facts
- Who runs it
- UConn Health
- Where
- West Hartford, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 64 people enrolled
- Started
- 20 Nov 2023
- Ended
- 20 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- MAPP
- Record updated
- 12 August 2026
Who can take part
- Age
- 6 years to 17 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- 6-17 years of age
- Have elevated anxiety symptoms as indicated by a total Screen for Child Anxiety Rated Disorders score between 20 and 55 based on parent and/or child report
- PCPs must have a PA, RN, NP, APRN or MD degree and be at least a part time employee in a primary care setting. There are no other inclusion/exclusion criteria
Who cannot take part
- Are receiving psychosocial mental health treatment for anxiety
- Have a medical or psychiatric condition contraindicating participation (e.g., suicidality) based on clinical interview
Where in United States
- UConn HealthWest Hartford, United States
About the trial
What the trial wants to find out
The goal of this clinical trial is to conduct a randomized controlled trial to enhance the capacity of pediatric primary care providers to assist their patients who struggle with anxiety.
Read full original descriptionShow less
The study aims to refine and assess the feasibility of the Anxiety Action Plan (AxAP), a brief intervention to reduce pediatric anxiety, delivered by primary care providers (PCPs) in community pediatric primary care clinics. The goal of the AxAP is to enhance the capacity of PCPs to identify and intervene with anxious youth, which will enhance access to care in general and especially in locations with few mental health specialists. PCPs participating in this study will attend a training, administer the intervention to enrolled youth assigned to the MAPP condition, participate in coaching sessions, and fill out study questionnaires. Families participating in this study will complete evaluations with the study team, receive the intervention from their PCP (if assigned to the MAPP condition), and fill out study questionnaires. Researchers will compare the MAPP intervention to Enhanced Usual Care (EUC; consisting of videos, handouts, and other resources for anxiety reduction) to see the differences, if any, in child outcomes.
The 2 groups in the trial
- Managing Anxiety in Pediatric Primary Care (MAPP)Treatment being tested
Participants receive approximately 4 sessions of a primary care provider-delivered intervention for reducing youth anxiety symptoms based on exposure therapy.
Treatment: MAPP
- Enhanced Usual Care (EUC)Placebo, for comparison
Participants receive a list of resources on how to reduce anxiety (e.g., videos, books, etc.).
Treatment: MAPP
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Enhancing the Capacity of Pediatric Primary Care Providers: A Pilot Trial of Anxiety Action Plan
- Record updated
- 12 August 2026